FDA Targets DermaTox Maker In Year’s First Published Warnings To Cosmetics Firms

Healthy Habits reacts indignantly to FDA’s warning about testimonials for DermaTox products featured on its website, which the agency says identify the items as unapproved drugs. Aegeia Skin Care also receives a warning letter for structure/function and disease-treatment claims on its facial- and body-care products.

StormuSkyWarningSign_1200x675

FDA’s warning letter activity in the cosmetics space appeared to drop off steeply last fall, with not a peep from the agency for months, but newly published letters signal FDA’s continued surveillance of the marketplace for excessive claims on skin-care products.

Agency officials indicated last year in exchanges with lawmakers that the roughly 30 warning letters to skin-care companies in 2016...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation